Armata Pharmaceuticals Statistics Share Statistics Armata Pharmaceuticals has 36.19M
shares outstanding. The number of shares has increased by 0.03%
in one year.
Shares Outstanding 36.19M Shares Change (YoY) 0.03% Shares Change (QoQ) 0.03% Owned by Institutions (%) 2.05% Shares Floating 10.8M Failed to Deliver (FTD) Shares 210 FTD / Avg. Volume 0.08%
Short Selling Information The latest short interest is 67.23K, so 0.19% of the outstanding
shares have been sold short.
Short Interest 67.23K Short % of Shares Out 0.19% Short % of Float 0.63% Short Ratio (days to cover) 3.96
Valuation Ratios The PE ratio is -3.54 and the forward
PE ratio is -3.21.
Armata Pharmaceuticals's PEG ratio is
0.05.
PE Ratio -3.54 Forward PE -3.21 PS Ratio 12.93 Forward PS 9.8 PB Ratio -1.39 P/FCF Ratio -1.7 PEG Ratio 0.05
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Armata Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.23,
with a Debt / Equity ratio of -2.63.
Current Ratio 0.23 Quick Ratio 0.23 Debt / Equity -2.63 Debt / EBITDA -18.47 Debt / FCF -3.21 Interest Coverage -3.95
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $86.23K Profits Per Employee $-315.27K Employee Count 60 Asset Turnover 0.06 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -7.45% in the
last 52 weeks. The beta is 1, so Armata Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1 52-Week Price Change -7.45% 50-Day Moving Average 2.17 200-Day Moving Average 1.98 Relative Strength Index (RSI) 52.64 Average Volume (20 Days) 247,114
Income Statement In the last 12 months, Armata Pharmaceuticals had revenue of 5.17M
and earned -18.92M
in profits. Earnings per share was -0.52.
Revenue 5.17M Gross Profit 3.85M Operating Income -42.44M Net Income -18.92M EBITDA -6.85M EBIT -8.17M Earnings Per Share (EPS) -0.52
Full Income Statement Balance Sheet The company has 9.29M in cash and 126.52M in
debt, giving a net cash position of -117.22M.
Cash & Cash Equivalents 9.29M Total Debt 126.52M Net Cash -117.22M Retained Earnings -327.74M Total Assets 87.25M Working Capital -97.37M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -37.55M
and capital expenditures -1.88M, giving a free cash flow of -39.43M.
Operating Cash Flow -37.55M Capital Expenditures -1.88M Free Cash Flow -39.43M FCF Per Share -1.09
Full Cash Flow Statement Margins Gross margin is 74.39%, with operating and profit margins of -820.18% and -365.6%.
Gross Margin 74.39% Operating Margin -820.18% Pretax Margin -365.6% Profit Margin -365.6% EBITDA Margin -132.37% EBIT Margin -820.18% FCF Margin -762.08%
Dividends & Yields ARMP does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ARMP is $9,
which is 281.4% higher than the current price. The consensus rating is "Strong Buy".
Price Target $9 Price Target Difference 281.4% Analyst Consensus Strong Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on May 10, 2019. It was a
backward
split with a ratio of 1:14.
Last Split Date May 10, 2019 Split Type backward Split Ratio 1:14
Scores Altman Z-Score -5.86 Piotroski F-Score 1
